Stay updated on Daratumumab & DLI for Relapsed AML Clinical Trial

Sign up to get notified when there's something new on the Daratumumab & DLI for Relapsed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab & DLI for Relapsed AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2; no user-facing content changes are evident.
    Difference
    0.1%
    Check dated 2026-04-19T13:38:20.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision history updated: added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T19:49:39.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-07T05:26:44.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    A minor site version update from v3.4.1 to v3.4.2 with no visible changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:33:53.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.0 to v3.4.1; no study-related content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T14:21:54.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    The page shows a site revision update from v3.3.3 to v3.3.4 in the footer, with no visible changes to study details, eligibility criteria, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T03:01:28.000Z thumbnail image

Stay in the know with updates to Daratumumab & DLI for Relapsed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab & DLI for Relapsed AML Clinical Trial page.